Cambridge Investment Research Advisors, Inc. Quidel Ortho Corp Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 13, 2022	BUY	$89.06 - $117.64 $218,731 - $288,923	2,456 New	2,456 $238,000

Others Institutions Holding QDEL

# of Institutions

292

Shares Held

67.7M

Call Options Held

337K

Put Options Held

134K

T. Rowe Price Investment Management, Inc. Baltimore, MD

9.4M
Shares

$362 Million
0.26% of portfolio
Carlyle Group Inc. Washington, DC

8.26M
Shares

$318 Million
56.7% of portfolio
Vanguard Group Inc Valley Forge, PA

6.05M
Shares

$233 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$188 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

4.2M
Shares

$162 Million
5.33% of portfolio

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.58B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account